Victory Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.73M Buy
100,565
+19,450
+24% +$1.52M 0.01% 1168
2025
Q4
$6.4M Buy
81,115
+16,971
+26% +$1.47M ﹤0.01% 1223
2025
Q3
$5.88M Sell
64,144
-15,560
-20% -$1.27M ﹤0.01% 1287
2025
Q2
$5.2M Buy
79,704
+62,841
+373% +$4.09M ﹤0.01% 1310
2025
Q1
$1.13M Buy
16,863
+3,086
+22% +$184K ﹤0.01% 1747
2024
Q4
$762K Buy
13,777
+858
+7% +$49.3K ﹤0.01% 1916
2024
Q3
$771K Buy
12,919
+7,825
+154% +$477K ﹤0.01% 1880
2024
Q2
$324K Sell
5,094
-1,735
-25% -$113K ﹤0.01% 2079
2024
Q1
$472K Buy
+6,829
New +$412K ﹤0.01% 2001
2022
Q4
Sell
-19,665
Closed -$632K 2592
2022
Q3
$632K Sell
19,665
-359
-2% -$12.3K ﹤0.01% 1943
2022
Q2
$594K Buy
20,024
+840
+4% +$24.2K ﹤0.01% 1972
2022
Q1
$566K Sell
19,184
-5,945
-24% -$222K ﹤0.01% 2080
2021
Q4
$1.16M Sell
25,129
-2,994
-11% -$129K ﹤0.01% 1777
2021
Q3
$923K Sell
28,123
-4,177
-13% -$130K ﹤0.01% 1902
2021
Q2
$1.13M Sell
32,300
-25,493
-44% -$867K ﹤0.01% 1849
2021
Q1
$2.09M Buy
+57,793
New +$1.81M ﹤0.01% 1640
2020
Q2
Sell
-25,334
Closed -$1.03M 2536
2020
Q1
$1.03M Buy
25,334
+10,151
+67% +$540K ﹤0.01% 1837
2019
Q4
$936K Buy
15,183
+6,652
+78% +$441K ﹤0.01% 1773
2019
Q3
$622K Buy
8,531
+6,792
+391% +$508K ﹤0.01% 1815
2019
Q2
$143K Sell
1,739
-3,023
-63% -$215K ﹤0.01% 1497
2019
Q1
$336K Buy
+4,762
New +$280K ﹤0.01% 1419
2017
Q3
Sell
-1,905
Closed -$89K 1810
2017
Q2
$89K Buy
1,905
+284
+18% +$13.7K ﹤0.01% 1693
2017
Q1
$80K Buy
1,621
+615
+61% +$34.5K ﹤0.01% 1686
2016
Q4
$61K Sell
1,006
-25
-2% -$1.53K ﹤0.01% 1685
2016
Q3
$68K Buy
+1,031
New +$64.5K ﹤0.01% 1656

Other funds holding ANIP